Hulimane Shivaswamy Rashmi, Binulal Pranav, Benoy Aloysious, Lakshmiramanan Kaushik, Bhaskar Nitu, Pandya Hardik Jeetendra
Department of Electronic Systems Engineering, Indian Institute of Science, Bangalore 560012, India.
ACS Mater Au. 2024 Nov 28;5(1):115-140. doi: 10.1021/acsmaterialsau.4c00125. eCollection 2025 Jan 8.
The delivery of molecules, such as DNA, RNA, peptides, and certain hydrophilic drugs, across the epidermal barrier poses a significant obstacle. Microneedle technology has emerged as a prominent area of focus in biomedical research because of its ability to deliver a wide range of biomolecules, vaccines, medicines, and other substances through the skin. Microneedles (MNs) form microchannels by disrupting the skin's structure, which compromises its barrier function, and facilitating the easy penetration of drugs into the skin. These devices enhance the administration of many therapeutic substances to the skin, enhancing their stability. Transcutaneous delivery of medications using a microneedle patch offers advantages over conventional drug administration methods. Microneedles containing active substances can be stimulated by different internal and external factors to result in the regulated release of the substances. To achieve efficient drug administration to the desired location, it is necessary to consider the design of needles with appropriate optimized characteristics. The choice of materials for developing and manufacturing these devices is vital in determining the pharmacodynamics and pharmacokinetics of drug delivery. This article provides the most recent update and overview of the numerous microneedle systems that utilize different activators to stimulate the release of active components from the microneedles. Further, it discusses the materials utilized for producing microneedles and the design strategies important in managing the release of drugs. An explanation of the commonly employed fabrication techniques in biomedical applications and electronics, particularly for integrated microneedle drug delivery systems, is discussed. To successfully implement microneedle technology in clinical settings, it is essential to comprehensively assess several factors, such as biocompatibility, drug stability, safety, and production cost. Finally, an in-depth review of these criteria and the difficulties and potential future direction of microneedles in delivering drugs and monitoring diseases is explored.
诸如DNA、RNA、肽和某些亲水性药物等分子穿过表皮屏障是一个重大障碍。微针技术因其能够通过皮肤递送多种生物分子、疫苗、药物和其他物质而成为生物医学研究中一个备受关注的重要领域。微针通过破坏皮肤结构形成微通道,这会损害其屏障功能,并便于药物轻松渗透到皮肤中。这些装置增强了许多治疗性物质向皮肤的给药,提高了它们的稳定性。使用微针贴片进行药物的经皮递送比传统给药方法具有优势。含有活性物质的微针可以受到不同的内部和外部因素刺激,从而实现物质的可控释放。为了实现将药物有效递送至期望位置,有必要考虑设计具有适当优化特性的针。开发和制造这些装置的材料选择对于确定药物递送的药效学和药代动力学至关重要。本文提供了众多微针系统的最新进展和概述,这些系统利用不同的激活剂来刺激微针中活性成分的释放。此外,还讨论了用于生产微针的材料以及对药物释放管理很重要的设计策略。文中讨论了生物医学应用和电子领域中常用的制造技术,特别是用于集成微针药物递送系统的技术。为了在临床环境中成功应用微针技术,全面评估几个因素至关重要,例如生物相容性、药物稳定性、安全性和生产成本。最后,对这些标准以及微针在药物递送和疾病监测方面的困难及潜在未来方向进行了深入综述。
ACS Mater Au. 2024-11-28
Pharmaceutics. 2023-1-13
Biomed Microdevices. 2021-12-8
Recent Pat Drug Deliv Formul. 2011-5
Biomed Microdevices. 2023-6-6
Drug Deliv Transl Res. 2022-1
Polymers (Basel). 2021-7-22
Cyborg Bionic Syst. 2024-9-13
Biomimetics (Basel). 2024-8-2
Bioeng Transl Med. 2024-3-14
Front Bioeng Biotechnol. 2024-6-11
Adv Mater. 2024-8
J Mater Chem B. 2024-6-19
Adv Healthc Mater. 2024-9
Expert Opin Drug Deliv. 2024-11